Last reviewed 2026-05-26 · How we verify

Angeli Sulfone (GLUCOSULFONE)

Phase 2 active Small molecule ✓ Verified May 2026

Angeli Sulfone (generic name: GLUCOSULFONE) is a drug. It is currently in Phase 2 development.

Angeli Sulfone works by binding to specific proteins or receptors in the body, altering their function and leading to a therapeutic effect.

Angeli Sulfone is a small molecule with the synonyms GLUCOSULFONA, GLUCOSULFONE, GLUCOSULFONE FREE ACID, GLUCOSULPHONE FREE ACID, and SN-166 FREE ACID.

Likelihood of approval

15.3% vs 15.3% industry baseline

If approved by FDA: likely 2031–2034

Steps remaining: Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 2 → approval rate +15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2031–2034	—
EMA	EU	2032–2035	+0.7 yr
MHRA	GB	2032–2035	+0.7 yr
Health Canada	CA	2032–2036	+0.9 yr
TGA	AU	2032–2036	+1.2 yr
PMDA	JP	2032–2036	+1.5 yr
NMPA	CN	2033–2037	+2.3 yr
MFDS	KR	2032–2036	+1.4 yr
CDSCO	IN	2032–2037	+1.8 yr
ANVISA	BR	2033–2037	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	GLUCOSULFONE
Modality	Small molecule
Therapeutic area	Other
Phase	Phase 2

Mechanism of action

Imagine your body's cells are like a orchestra, and Angeli Sulfone is a conductor that helps the cells work together in a specific way to produce a desired outcome. By binding to certain proteins or receptors, Angeli Sulfone can influence the way cells communicate and respond to signals, leading to changes in the body's function. This can be beneficial for treating certain diseases or conditions, but it's a complex process that requires further research to fully understand.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Serum Tryptase Levels During Cardiac Surgery, Diagnosis and Treatment Decisions for Allergic Reactions

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Angeli Sulfone CI brief — competitive landscape report
Angeli Sulfone updates RSS · CI watch RSS

Frequently asked questions about Angeli Sulfone

What is Angeli Sulfone?

Angeli Sulfone (GLUCOSULFONE) is a Small molecule drug.

How does Angeli Sulfone work?

Angeli Sulfone works by binding to specific proteins or receptors in the body, altering their function and leading to a therapeutic effect.

What is the generic name of Angeli Sulfone?

GLUCOSULFONE is the generic (nonproprietary) name of Angeli Sulfone.

What development phase is Angeli Sulfone in?

Angeli Sulfone is in Phase 2.

Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing